KORTNI SORBELLO: Open Payments
NPI 1467892323 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 76 payments from 19 companies in 2025. Trend: 2023 $1,570 · 2024 $2,018 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $350 |
| Lilly USA, LLC | 12 | $254 |
| PFIZER INC. | 8 | $179 |
| Insulet Corporation | 1 | $169 |
| Amgen Inc. | 16 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $113 |
| Novo Nordisk Inc | 3 | $92 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| Exact Sciences Corporation | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
Products named: AIRSUPRA, OMNIPOD, NURTEC ODT, MOUNJARO, JARDIANCE, Kerendia, Wegovy, OTEZLA.
Industry payments across MD — which companies pay providers there.
